|
Prescription Drug Search
Strengths available for Eligard kit:
Eligard kit 3.75mg
Eligard kit 7.5mg
Eligard kit 11.25mg
Eligard kit 22.5mg
Eligard kit 30mg
Eligard kit 45mg
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about CancerDrugsDirect.com
List of countries where we can ship Eligard:
- Algeria
- Argentina
- Aruba
- Austria
- Azerbaijan
- Bahrain
- Belarus
- China
- Croatia
- Cuba
- Egypt
- El Salvador
- Fiji
- Finland
- Gibraltar
- Greenland
- Hong Kong
- India
- Indonesia
- Iraq
- Ireland
- Jamaica
- Kuwait
- Latvia
- Lithuania
- Mauritius
- Netherlands
- Netherlands Antilles
- Poland
- Qatar
- Romania
- Seychelles
- Slovakia
- Switzerland
- Taiwan
- Turkey
- United Kingdom, UK
- United States, US
- Uruguay
- Vanuatu
Latest news releases on Eligard:
Medigene Receives EUR 5 Million Milestone Payment from Astellas - Yahoo Finance
MediGene AG (Frankfurt, Prime Standard, MDG) received a EUR 5 million milestone payment from Astellas Pharma Europe Ltd. This is the final payment for the transfer of rights for the cancer drug, Eligard ®, from Medigene to Astellas. Medigene ...
Medigene reports financial and operating results for first quarter of 2012 - ad-hoc-news.de
On the other hand total revenue includes other income totaling EUR 1,018 thousand (Q1 2011: EUR 268 thousand), which consists mainly of Eligard(®) product sales. Since March 2011, this corresponds to 2% of the net sales generated by Astellas and is posted ...
QLT Announces Notification of Legal Proxy Action in Advance of Annual Meeting of Stockholders - msnbc.com
The QLT Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6933 Visudyne® is a registered trademark of Novartis AG Eligard® is a registered trademark of Sanofi S.A. QLT Inc. is listed on The NASDAQ Stock Market under ...
PRESS RELEASE: Medigene reports financial and operating results for first quarter of 2012 - finanzen.net
Last year's reporting period included a non-recurring item, specifically EUR 20 million received for the sale of the Eligard(®) rights to Medigene's marketing partner Astellas, which was recorded as "discontinued operations" according to IFRS. Combining ...
QLT Responds With an Open Letter to Stockholders - msnbc.com
The QLT Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6933 Visudyne® is a registered trademark of Novartis AG Eligard® is a registered trademark of Sanofi S.A. QLT Inc. is listed on The NASDAQ Stock Market under the trading ...
